IHS Chemical Week

People & Business :: M&A

Reckitt Benckiser likely to sell pharma business

9:03 AM MDT | October 23, 2013 | Natasha Alperowicz

Consumer goods group Reckitt Benckiser (Slough, UK) is looking at options for its pharmaceuticals business, the company said on Tuesday. “We are commencing a strategic review of the business and will consider all options for maximizing value for our shareholders. We expect the review to take some time and will update shareholders during the course of 2014,” the company says.   Reckitt Benckiser’s pharma business is essentially its Suboxone drug, which is used to treat addiction to opioids, such as heroin. The United States accounts for more...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa